Topics

After AbbVie Acquisition, Allergan's Saunders Can Walk Away with $39 Million

20:00 EDT 14 Aug 2019 | BioSpace

According to a regulatory filing, Saunders will walk away with $14.9 million in cash and $23.6 million in equity, mostly stock based on performance.

Original Article: After AbbVie Acquisition, Allergan's Saunders Can Walk Away with $39 Million

NEXT ARTICLE

More From BioPortfolio on "After AbbVie Acquisition, Allergan's Saunders Can Walk Away with $39 Million"

Quick Search